| James Kihara |
ACAD |
Restricted Stock Units |
Award |
|
|
|
6,332 |
6,332 |
06 Mar 2026 |
Direct |
| James Kihara |
ACAD |
Stock Option (Right to Buy) |
Award |
|
|
|
21,766 |
21,766 |
06 Mar 2026 |
Direct |
| Jennifer J. Rhodes |
ACAD |
Restricted Stock Units |
Award |
|
|
|
26,382 |
26,382 |
06 Mar 2026 |
Direct |
| Jennifer J. Rhodes |
ACAD |
Stock Option (Right to Buy) |
Award |
|
|
|
90,691 |
90,691 |
06 Mar 2026 |
Direct |
| Mark C. Schneyer |
ACAD |
Restricted Stock Units |
Award |
|
|
|
26,382 |
26,382 |
06 Mar 2026 |
Direct |
| Mark C. Schneyer |
ACAD |
Stock Option (Right to Buy) |
Award |
|
|
|
90,691 |
90,691 |
06 Mar 2026 |
Direct |
| Thomas Garner |
ACAD |
Restricted Stock Units |
Award |
|
|
|
28,493 |
28,493 |
06 Mar 2026 |
Direct |
| Thomas Garner |
ACAD |
Stock Option (Right to Buy) |
Award |
|
|
|
97,947 |
97,947 |
06 Mar 2026 |
Direct |
| Elizabeth H.z. Thompson |
ACAD |
Restricted Stock Units |
Award |
|
|
|
29,548 |
29,548 |
06 Mar 2026 |
Direct |
| Elizabeth H.z. Thompson |
ACAD |
Stock Option (Right to Buy) |
Award |
|
|
|
101,574 |
101,574 |
06 Mar 2026 |
Direct |
| Adams Catherine Owen |
ACAD |
Restricted Stock Units |
Award |
|
|
|
76,509 |
76,509 |
06 Mar 2026 |
Direct |
| Adams Catherine Owen |
ACAD |
Stock Option (Right to Buy) |
Award |
|
|
|
263,005 |
263,005 |
06 Mar 2026 |
Direct |
| Jennifer J. Rhodes |
ACAD |
Common Stock |
Sale |
-47.7% |
$162,491 |
$23.38 |
-6,950 |
7,609 |
09 Feb 2026 |
Direct |
| Jennifer J. Rhodes |
ACAD |
Common Stock |
Options Exercise |
801.5% |
|
|
12,944 |
14,559 |
06 Feb 2026 |
Direct |
| Jennifer J. Rhodes |
ACAD |
Restricted Stock Units |
Options Exercise |
-50% |
|
|
-12,944 |
12,945 |
06 Feb 2026 |
Direct |
| Mark C. Schneyer |
ACAD |
Common Stock |
Sale |
-16.1% |
$243,114 |
$23.69 |
-10,262 |
53,338 |
18 Nov 2025 |
Direct |
| James Kihara |
ACAD |
Common Stock |
Sale |
-14% |
$96,754 |
$23.69 |
-4,084 |
25,058 |
18 Nov 2025 |
Direct |
| Mark C. Schneyer |
ACAD |
Common Stock |
Options Exercise |
45.3% |
|
|
19,826 |
63,600 |
17 Nov 2025 |
Direct |
| Mark C. Schneyer |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-19,826 |
0 |
17 Nov 2025 |
Direct |
| James Kihara |
ACAD |
Common Stock |
Options Exercise |
37.4% |
|
|
7,932 |
29,142 |
17 Nov 2025 |
Direct |
| James Kihara |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-7,932 |
0 |
17 Nov 2025 |
Direct |
| James M. Daly |
ACAD |
Common Stock |
Sale |
-88.1% |
$670,983 |
$22.37 |
-30,000 |
4,041 |
10 Nov 2025 |
Direct |
| Mark C. Schneyer |
ACAD |
Common Stock |
Sale |
-7.45% |
$82,728 |
$23.65 |
-3,498 |
43,447 |
15 Sep 2025 |
Direct |
| Mark C. Schneyer |
ACAD |
Common Stock |
Award |
17% |
|
|
6,815 |
46,945 |
12 Sep 2025 |
Direct |
| Elizabeth A. Garofalo |
ACAD |
Common Stock |
Sale |
-5.93% |
$41,560 |
$25.98 |
-1,600 |
25,382 |
02 Sep 2025 |
Direct |
| Mark C. Schneyer |
ACAD |
Common Stock |
Sale |
-35.4% |
$554,024 |
$25.18 |
-22,000 |
40,130 |
18 Aug 2025 |
Direct |
| Laura Brege |
ACAD |
Common Stock |
Sale |
-48.9% |
$314,634 |
$21.78 |
-14,446 |
15,095 |
04 Jun 2025 |
Direct |
| Daniel B. Soland |
ACAD |
Common Stock |
Options Exercise |
27.1% |
|
|
9,387 |
44,041 |
29 May 2025 |
Direct |
| Daniel B. Soland |
ACAD |
Restricted Stock Units |
Award |
|
|
|
8,107 |
8,107 |
29 May 2025 |
Direct |
| Daniel B. Soland |
ACAD |
Director Stock Options (Right to Buy) |
Award |
|
|
|
13,793 |
13,793 |
29 May 2025 |
Direct |
| Daniel B. Soland |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-9,387 |
0 |
29 May 2025 |
Direct |
| Adora Ndu |
ACAD |
Common Stock |
Options Exercise |
60.9% |
|
|
9,387 |
24,801 |
29 May 2025 |
Direct |
| Adora Ndu |
ACAD |
Restricted Stock Units |
Award |
|
|
|
8,107 |
8,107 |
29 May 2025 |
Direct |
| Adora Ndu |
ACAD |
Director Stock Options (Right to Buy) |
Award |
|
|
|
13,793 |
13,793 |
29 May 2025 |
Direct |
| Adora Ndu |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-9,387 |
0 |
29 May 2025 |
Direct |
| Edmund Harrigan |
ACAD |
Common Stock |
Options Exercise |
36.6% |
|
|
9,387 |
35,041 |
29 May 2025 |
Direct |
| Edmund Harrigan |
ACAD |
Restricted Stock Units |
Award |
|
|
|
8,107 |
8,107 |
29 May 2025 |
Direct |
| Edmund Harrigan |
ACAD |
Director Stock Options (Right to Buy) |
Award |
|
|
|
13,793 |
13,793 |
29 May 2025 |
Direct |
| Edmund Harrigan |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-9,387 |
0 |
29 May 2025 |
Direct |
| Elizabeth A. Garofalo |
ACAD |
Common Stock |
Options Exercise |
53.4% |
|
|
9,387 |
26,982 |
29 May 2025 |
Direct |
| Elizabeth A. Garofalo |
ACAD |
Restricted Stock Units |
Award |
|
|
|
8,107 |
8,107 |
29 May 2025 |
Direct |
| Elizabeth A. Garofalo |
ACAD |
Director Stock Options (Right to Buy) |
Award |
|
|
|
13,793 |
13,793 |
29 May 2025 |
Direct |
| Elizabeth A. Garofalo |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-9,387 |
0 |
29 May 2025 |
Direct |
| James M. Daly |
ACAD |
Common Stock |
Options Exercise |
38.1% |
|
|
9,387 |
34,041 |
29 May 2025 |
Direct |
| James M. Daly |
ACAD |
Restricted Stock Units |
Award |
|
|
|
8,107 |
8,107 |
29 May 2025 |
Direct |
| James M. Daly |
ACAD |
Director Stock Options (Right to Buy) |
Award |
|
|
|
13,793 |
13,793 |
29 May 2025 |
Direct |
| James M. Daly |
ACAD |
Restricted Stock Units |
Options Exercise |
-100% |
|
|
-9,387 |
0 |
29 May 2025 |
Direct |
| Laura Brege |
ACAD |
Common Stock |
Options Exercise |
46.6% |
|
|
9,387 |
29,541 |
29 May 2025 |
Direct |
| Laura Brege |
ACAD |
Restricted Stock Units |
Award |
|
|
|
8,107 |
8,107 |
29 May 2025 |
Direct |
| Laura Brege |
ACAD |
Director Stock Options (Right to Buy) |
Award |
|
|
|
13,793 |
13,793 |
29 May 2025 |
Direct |